Karo Bio AB

Quick facts

Phase 2 pipeline

• Eprotirome and ezetimibe · Cardiovascular
  Eprotirome is a thyroid hormone receptor antagonist, and ezetimibe is a cholesterol absorption inhibitor.
• KB2115

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Karo Bio AB portfolio CI brief
• Karo Bio AB pipeline updates RSS

Related

• Sector hub: All tracked pharma companies